Ankaferd Blood Stopper with antibiofilm potential successfully inhibits the extracellular matrix degradation enzymes and promotes wound healing of 3T3 fibroblasts in vitro

Creative Commons License

BORAN R., BAYGAR T., SARAÇ N., UĞUR A.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.48, no.3, pp.627-634, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 48 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.3906/sag-1712-80
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.627-634
  • Keywords: Ankaferd Blood Stopper, enzyme inhibition, antibiofilm, wound healing, CONTROLLED CLINICAL-TRIAL, HEMOSTATIC AGENT, ANTIOXIDANT, BIOFILMS, REPAIR, SKIN
  • Gazi University Affiliated: Yes

Abstract

Background/aim: The potential inhibitory effects of Ankaferd Blood Stopper (ABS) against biofilm formation of oral microorganisms and its capacity for collagenase, hyaluronidase, and elastase inhibitions that have important roles in wound healing have been investigated.